# SIGNATURE Study : DCB (Legflow) vs POBA in Fempop Arteries

> **NCT04971772** · — · ACTIVE_NOT_RECRUITING · sponsor: **Cardionovum GmbH** · enrollment: 150 (actual)

## Conditions studied

- Peripheral Arterial Disease
- Superficial Femoral Artery Stenosis
- Angiopathy, Peripheral

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04971772
- **Lead sponsor:** Cardionovum GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-06-08
- **Primary completion:** 2026-12
- **Final completion:** 2028-01
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2026-03-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04971772

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04971772, "SIGNATURE Study : DCB (Legflow) vs POBA in Fempop Arteries". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT04971772. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*